샘플 요청 목록

 카트 문의
시장보고서
상품코드
1798304

전체 유전체 증폭(WGA) 시장

Whole Genome Amplification (WGA)
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 396 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 전체 유전체 증폭(WGA) 시장은 2030년까지 520만 달러에 이를 전망

2024년에 360만 달러로 추정되는 전체 유전체 증폭(WGA) 세계 시장은 2024-2030년간 CAGR 6.2%로 성장하여 2030년에는 520만 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 싱글 셀 WGA 키트는 CAGR 5.2%를 나타내고, 분석 기간 종료까지 160만 달러에 이를 것으로 예측됩니다. 완전 WGA 키트 부문의 성장률은 분석 기간중 CAGR6.8%로 추정됩니다.

미국 시장은 98만 1,000달러로 추정, 중국은 CAGR 9.5%로 성장 예측

미국의 전체 유전체 증폭(WGA) 시장은 2024년에 98만 1,000달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간 2024-2030년간 CAGR 9.5%로 성장을 지속하여, 2030년에는 예측 시장 규모 100만 달러에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 3.1%와 6.0%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 4.0%를 보일 전망입니다.

세계의 전체 유전체 증폭(WGA) 시장 - 주요 동향과 촉진요인 정리

ㅊ 증폭이 유전체 연구와 분자진단을 어떻게 변화시킬 것인가?

전장유전체증폭(WGA)은 유전체 과학의 혁신적 기술로 등장하여, 연구자들은 최소한의 샘플이나 열화된 샘플에서 대량의 DNA를 생성할 수 있게 되었습니다. 이 과정은 착상 전 유전자 진단, 단일 세포 분석, 법의학, 고대 DNA 연구 등 시료의 양이 본질적으로 제한되어 있는 분야에서 특히 중요합니다. WGA는 전체 유전체의 편향되지 않은 증폭을 가능하게 하며, 시퀀싱, 유전형질 분석, 마이크로어레이 분석과 같은 다운스트림 용도를 위해 유전적 내용과 구조를 유지합니다. 미량의 DNA를 다룰 수 있는 능력은 환자 고유의 유전 정보를 진단과 치료의 조정에 사용하는 개인 맞춤형 의료에서 특히 가치가 있습니다. WGA는 단 하나의 세포에서 종합적인 유전체 프로파일을 생성할 수 있어 암 생물학, 희귀질환 연구, 생식의학 분야의 새로운 지평을 열었습니다. 또한 과학자들이 유전적 다양성, 돌연변이 패턴, 종을 초월한 진화적 관계를 더 잘 이해할 수 있게 해줍니다. 임상에서 WGA는 유전자 이상을 조기에 발견할 수 있도록 돕습니다. 민감도, 확장성, 범용성이 결합된 WGA는 제한된 생물학적 샘플과 고해상도 유전적 통찰력에 대한 수요 증가 사이의 간극을 메워주는 현대 유전체학의 기본 도구로 자리매김하고 있습니다.

WGA의 정확성과 효율성을 높이는 기술 발전은 무엇인가?

최근 기술 혁신은 전장유전체 증폭 기술의 성능, 신뢰성, 이용 편의성을 크게 향상시키고 있습니다. 폴리머라아제 효소, 완충 시스템, 열 사이클링 프로토콜의 개선으로 오류율과 편향성을 줄이고 보다 균일한 증폭이 가능해졌습니다. MDA(Multiple Displacement Amplification)와 같은 등온증폭법은 유전체를 높은 충실도로 증폭하고 염기서열의 왜곡을 최소화할 수 있어 인기를 얻고 있습니다. 마이크로플루이딕스 공학의 혁신은 또한 세포 용해 및 반응 조립을 위한 제어된 환경을 제공하여 시료의 손실과 오염을 최소화함으로써 단일 세포 WGA의 효율성을 향상시키고 있습니다. 자동화 및 고처리량 기능의 통합으로 실험실은 수백에서 수천 개의 샘플을 동시에 처리할 수 있으며, 이는 대규모 유전체학 프로젝트 및 임상 진단에 필수적입니다. 차세대 시퀀싱 플랫폼은 WGA 제품과의 호환성이 높아지고 있으며, 이 기술을 사용할 수 있는 용도의 범위를 더욱 확장하고 있습니다. 증폭 전후의 DNA 정량 및 무결성 분석과 같은 고도의 품질 관리 수단을 통해 고품질의 샘플만 하류 분석으로 진행되도록 보장합니다. 이러한 기술 개발은 증폭 결과를 개선할 뿐만 아니라, WGA를 보다 재현성이 높고, 비용 효율적이며, 광범위한 유전체 워크플로우에 적합하게 만들었습니다. 정밀의료와 실시간 유전자 데이터에 대한 수요가 계속 증가함에 따라 WGA 기술은 병행하여 진화하고 있으며, DNA 증폭을 위한 보다 합리적이고 정확한 솔루션을 제공할 것으로 기대되고 있습니다.

산업을 초월한 다양한 용도는 어떻게 WGA의 채택을 촉진하고 있는가?

홀유전체 증폭의 범용성은 학술 연구와 임상 연구뿐만 아니라 다양한 산업 분야에서의 채택을 촉진하고 있습니다. 생식의학에서 WGA는 착상 전 유전학적 검사에서 중요한 역할을 하고 있으며, 임상의가 체외수정 시 착상 전 배아에 유전적 장애가 있는지 여부를 선별할 수 있게 해줍니다. 종양학에서는 개별 암세포의 DNA를 증폭하여 종양 프로파일링 및 종양 내 이질성 연구를 지원합니다. 이는 표적치료제 개발이나 순환하는 종양세포나 무세포 DNA 샘플의 양이 일반적으로 적은 액체생검에서 특히 중요하게 여겨지고 있습니다. 법의학자들은 범죄 현장에서 발견된 미량 DNA의 증폭에 WGA를 활용하고 있으며, 고도로 열화된 것 또는 제한된 것에서도 신원 확인이 가능합니다. 환경 및 미생물 연구에서 WGA는 복잡한 생태계에서 배양할 수 없는 생물이나 희귀한 미생물 군집의 유전체 분석에 사용됩니다. 농업 연구에서는 제한된 조직 샘플을 이용한 식물 유전학 및 내병성 형질 연구에 WGA가 유용하게 활용되고 있습니다. 이 방법은 소량의 DNA 샘플을 사용하여 식단 및 피트니스 권장 사항을 조정하는 개인 맞춤형 영양학 및 웰빙 분야에서도 활용되고 있습니다. 규제 환경이 진화하고 데이터 기반 의사결정이 다양한 분야에서 주목을 받으면서 최소한의 입력으로 종합적인 유전 데이터를 생성하는 능력의 가치가 점점 더 커지고 있습니다. 이러한 광범위한 적용 가능성은 기존 시장과 신흥 시장 모두에서 WGA 기술에 대한 수요가 증가하고 있는 강력한 요인 중 하나입니다.

WGA 솔루션의 세계 확장을 주도하는 시장 역학은 무엇인가?

세계 전장유전체 증폭 시장은 과학적, 기술적, 상업적 요인의 수렴으로 빠르게 확대되고 있으며, 유전자 연구와 진단의 상황을 재구성하고 있습니다. 공공 기관과 민간 생명공학 기업 모두 유전체 연구에 대한 투자가 증가함에 따라 까다로운 시료에 대응할 수 있는 신뢰할 수 있는 증폭 기술에 대한 수요가 증가하고 있습니다. 액체 생검 및 단일 세포 분석에 사용되는 샘플링 기술의 지속적인 소형화로 인해 데이터 품질 저하 없이 소량의 유전물질을 증폭할 수 있는 WGA 솔루션에 대한 수요가 증가하고 있습니다. 개인 맞춤형 의료와 정밀 진단으로의 전환도 임상의와 연구자들이 개인별 치료 계획을 세우기 위해 종합적인 유전체 데이터를 요구하면서 WGA에 대한 관심을 높이고 있습니다. 학술 기관, 진단 실험실, 기술 제공업체 간의 협력으로 특정 용도와 워크플로우에 맞는 새로운 WGA 키트의 개발 및 검증이 가속화되고 있습니다. 고품질 DNA 입력에 의존하는 차세대 시퀀싱 기술의 가용성이 증가함에 따라 임상 및 연구 파이프라인에서 WGA의 관련성이 더욱 높아지고 있습니다. 많은 국가에서 유전자 검사 및 조기 질병 검진에 대한 규제적 지원은 유전자 도구의 광범위한 채택을 촉진하고 시장 침투를 위한 새로운 기회를 창출하고 있습니다. 또한, 소비자 유전체학 및 소비자 직접 유전자 검사의 부상으로 인해 쉽게 확장 및 표준화할 수 있는 샘플 친화적인 증폭 방법에 대한 수요가 증가하고 있습니다. 이러한 역동성이 결합되어 WGA는 세계 유전체학 생태계의 중요하고 빠르게 진화하는 요소로 자리매김하고 있습니다.

부문

유형(싱글 셀 WGA 키트, 완전 WGA 키트, WGA 재증폭 키트, WGA & 칩 DNA 키트, 기타 유형), 용도(Drug Discovery & Development, 진단, 연구, 법의학, 기타 용도), 최종사용자(제약 기업 및 바이오테크놀러지 기업 병원 및 클리닉 연구기관, 기타 최종사용자)

조사 대상 기업 예

  • BGI Group/MGI Tech
  • AgilentTechnologies
  • Applied Biosystems(Thermo Fisher)
  • BioSkryb Genomics
  • Complete Genomics
  • Fluidigm(Standard BioTools)
  • Illumina, Inc.
  • LGC Biosearch Technologies
  • Merck(Sigma-Aldrich)
  • MGI Tech
  • NanoString Technologies
  • New England Biolabs
  • Oxford Nanopore Technologies
  • PacBio(Pacific Biosciences)
  • Paragon Genomics
  • Promega Corporation
  • QIAGEN NV
  • Roche
  • ScienCell Analytics
  • Thermo Fisher Scientific

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.09.03

Global Whole Genome Amplification (WGA) Market to Reach US$5.2 Million by 2030

The global market for Whole Genome Amplification (WGA) estimated at US$3.6 Million in the year 2024, is expected to reach US$5.2 Million by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Single Cell WGA Kit, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.6 Million by the end of the analysis period. Growth in the Complete WGA Kit segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$981.0 Thousand While China is Forecast to Grow at 9.5% CAGR

The Whole Genome Amplification (WGA) market in the U.S. is estimated at US$981.0 Thousand in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Million by the year 2030 trailing a CAGR of 9.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Whole Genome Amplification (WGA) Market - Key Trends & Drivers Summarized

How Is Whole Genome Amplification Transforming Genomic Research and Molecular Diagnostics?

Whole Genome Amplification (WGA) has emerged as a transformative technique in genomic science, enabling researchers to generate large quantities of DNA from minimal or degraded samples. This process is particularly critical in fields where sample quantity is inherently limited, such as preimplantation genetic diagnosis, single-cell analysis, forensic science, and ancient DNA studies. WGA allows for the unbiased amplification of the entire genome, preserving the genetic content and structure for downstream applications like sequencing, genotyping, and microarray analysis. The ability to work with minute DNA quantities is especially valuable in personalized medicine, where patient-specific genetic information is used to tailor diagnostics and treatments. WGA ensures that a comprehensive genomic profile can be developed from as little as a single cell, opening new frontiers in cancer biology, rare disease research, and reproductive health. It is also enabling scientists to better understand genetic diversity, mutation patterns, and evolutionary relationships across species. In clinical settings, WGA supports the early detection of genetic abnormalities, often before traditional methods are feasible. The combination of sensitivity, scalability, and versatility is positioning WGA as a foundational tool in modern genomics, bridging the gap between limited biological samples and the growing demand for high-resolution genetic insights.

What Technological Advancements Are Enhancing the Precision and Efficiency of WGA?

Recent technological innovations are significantly enhancing the performance, reliability, and accessibility of Whole Genome Amplification techniques. Improvements in polymerase enzymes, buffer systems, and thermal cycling protocols are enabling more uniform amplification with reduced error rates and bias. Isothermal amplification methods such as Multiple Displacement Amplification (MDA) have gained traction due to their ability to amplify genomes with high fidelity and minimal sequence distortion. Innovations in microfluidics are also improving the efficiency of single-cell WGA by providing controlled environments for cell lysis and reaction assembly, minimizing sample loss and contamination. The integration of automation and high-throughput capabilities is allowing laboratories to process hundreds or even thousands of samples simultaneously, which is crucial for large-scale genomics projects and clinical diagnostics. Next-generation sequencing platforms are increasingly compatible with WGA products, further expanding the range of applications in which this technique can be used. Advanced quality control measures, such as pre- and post-amplification DNA quantification and integrity analysis, are ensuring that only high-quality samples proceed to downstream analysis. These technological developments are not only improving amplification outcomes but also making WGA more reproducible, cost-effective, and suitable for a wider array of genomic workflows. As the demand for precision medicine and real-time genetic data continues to grow, WGA technologies are expected to evolve in parallel, offering more streamlined and accurate solutions for DNA amplification.

How Are Diverse Applications Across Industries Fueling the Adoption of WGA?

The versatility of Whole Genome Amplification is driving its adoption across a broad spectrum of industries beyond just academic and clinical research. In reproductive health, WGA is playing a crucial role in preimplantation genetic testing, allowing clinicians to screen embryos for genetic disorders before implantation during in vitro fertilization procedures. In oncology, the technique supports tumor profiling and the study of intratumoral heterogeneity by amplifying DNA from individual cancer cells. This has become especially relevant in the development of targeted therapies and liquid biopsies, where circulating tumor cells and cell-free DNA samples are typically low in quantity. Forensic scientists rely on WGA to amplify trace DNA found at crime scenes, enabling identity verification even from highly degraded or limited material. In environmental and microbial studies, WGA is used to analyze the genomes of unculturable organisms or rare microbial communities in complex ecosystems. Agricultural research benefits from WGA in studying plant genetics and disease resistance traits using limited tissue samples. The method is also being adopted in personalized nutrition and wellness sectors, where small DNA samples are used to tailor diet and fitness recommendations. As regulatory environments evolve and data-driven decision-making gains prominence in diverse sectors, the ability to generate comprehensive genetic data from minimal inputs is becoming increasingly valuable. This widespread applicability is one of the strongest forces behind the rising demand for WGA technologies across both established and emerging markets.

What Market Dynamics Are Driving the Global Expansion of WGA Solutions?

The global Whole Genome Amplification market is expanding rapidly due to a convergence of scientific, technological, and commercial factors that are reshaping the landscape of genetic research and diagnostics. Increasing investment in genomics research by both public institutions and private biotechnology firms is fueling the need for reliable amplification technologies capable of handling challenging samples. The continued miniaturization of sampling techniques, such as those used in liquid biopsy and single-cell analysis, is creating a growing demand for WGA solutions that can amplify small amounts of genetic material without compromising data quality. The shift toward personalized medicine and precision diagnostics is also amplifying interest in WGA as clinicians and researchers seek comprehensive genomic data to guide individualized treatment plans. Partnerships between academic institutions, diagnostic laboratories, and technology providers are accelerating the development and validation of new WGA kits tailored for specific applications and workflows. The growing availability of next-generation sequencing technologies, which rely on high-quality DNA input, is further boosting the relevance of WGA in clinical and research pipelines. Regulatory support for genetic testing and early disease screening in many countries is encouraging broader adoption of genetic tools, creating new opportunities for market penetration. Additionally, the rise of consumer genomics and direct-to-consumer genetic testing is increasing demand for sample-friendly amplification methods that can be easily scaled and standardized. Together, these dynamics are ensuring that WGA remains a critical and rapidly evolving component of the global genomics ecosystem.

SCOPE OF STUDY:

The report analyzes the Whole Genome Amplification (WGA) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit, Other Types); Application (Drug Discovery & Development Application, Diagnostics Application, Research Application, Forensics Application, Other Applications); End-User (Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • BGI Group / MGI Tech
  • AgilentTechnologies
  • Applied Biosystems (Thermo Fisher)
  • BioSkryb Genomics
  • Complete Genomics
  • Fluidigm (Standard BioTools)
  • Illumina, Inc.
  • LGC Biosearch Technologies
  • Merck (Sigma-Aldrich)
  • MGI Tech
  • NanoString Technologies
  • New England Biolabs
  • Oxford Nanopore Technologies
  • PacBio (Pacific Biosciences)
  • Paragon Genomics
  • Promega Corporation
  • QIAGEN NV
  • Roche
  • ScienCell Analytics
  • Thermo Fisher Scientific

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Whole Genome Amplification (WGA) - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Single-Cell Genomics Throws the Spotlight on High-Fidelity WGA Techniques
    • Expansion of Personalized Medicine and Genomic Research Spurs Growth in WGA Applications
    • Advancements in Next-Generation Sequencing Expand Addressable Market for Pre-Amplification Solutions
    • Increasing Use of Liquid Biopsies and Rare Cell Analysis Strengthens the Business Case for Sensitive WGA Kits
    • Growth in Non-Invasive Prenatal Testing (NIPT) Drives Adoption of Low-Input DNA Amplification Technologies
    • Forensic and Ancient DNA Analysis Needs Propel Innovation in Ultra-Low Input WGA Solutions
    • Microbiome and Metagenomic Studies Highlight the Role of Bias-Minimized WGA Protocols
    • Synthetic Biology and Gene Editing Applications Generate Opportunities for High-Precision Amplification Tools
    • Global Focus on Infectious Disease Surveillance Sustains Growth in Pathogen Genomic Amplification
    • Automation and Workflow Integration Drive Adoption of WGA in Clinical and Lab Automation Systems
    • Research in Isothermal and PCR-Free Amplification Technologies Fuel Competitive Innovation
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Whole Genome Amplification (WGA) Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Whole Genome Amplification (WGA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Whole Genome Amplification (WGA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Single Cell WGA Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Single Cell WGA Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Single Cell WGA Kit by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Complete WGA Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Complete WGA Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Complete WGA Kit by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for WGA Reamplification Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for WGA Reamplification Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for WGA Reamplification Kit by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for WGA & Chip DNA Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for WGA & Chip DNA Kit by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for WGA & Chip DNA Kit by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Forensics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Forensics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Forensics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Pharma & Biotech Companies End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Pharma & Biotech Companies End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Hospitals & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Hospitals & Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Research Institutes End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Research Institutes End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 43: World 16-Year Perspective for Research Institutes End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 46: World 16-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • JAPAN
    • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • CHINA
    • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 76: China 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 79: China 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 82: China 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • EUROPE
    • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Whole Genome Amplification (WGA) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Whole Genome Amplification (WGA) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • FRANCE
    • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 97: France 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 100: France 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 103: France 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • GERMANY
    • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 130: UK 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 136: Spain 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 137: Spain Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Spain Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 139: Spain 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 145: Russia 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 146: Russia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Russia Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 148: Russia 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Whole Genome Amplification (WGA) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Whole Genome Amplification (WGA) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 172: Australia 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 175: Australia 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 176: Australia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Australia Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 178: Australia 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • INDIA
    • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 179: India Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 181: India 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 184: India 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 185: India Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: India Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 187: India 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 190: South Korea 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 193: South Korea 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 194: South Korea Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: South Korea Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 196: South Korea 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Asia-Pacific Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Asia-Pacific 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Whole Genome Amplification (WGA) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Whole Genome Amplification (WGA) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 211: Latin America 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 214: Latin America 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 215: Latin America Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Latin America Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 217: Latin America 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 220: Argentina 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 223: Argentina 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 224: Argentina Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Argentina Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 226: Argentina 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 229: Brazil 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 232: Brazil 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 233: Brazil Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Brazil Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 235: Brazil 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 238: Mexico 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 241: Mexico 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 242: Mexico Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Mexico Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 244: Mexico 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Latin America Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 253: Rest of Latin America 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Whole Genome Amplification (WGA) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Whole Genome Amplification (WGA) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 259: Middle East 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 262: Middle East 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 263: Middle East Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Middle East Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 265: Middle East 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 268: Iran 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 271: Iran 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 272: Iran Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Iran Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 274: Iran 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 277: Israel 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 280: Israel 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 281: Israel Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Israel Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 283: Israel 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Saudi Arabia Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 292: Saudi Arabia 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 295: UAE 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 298: UAE 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 299: UAE Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: UAE Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 301: UAE 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Middle East Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 310: Rest of Middle East 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030
  • AFRICA
    • Whole Genome Amplification (WGA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Whole Genome Amplification (WGA) by Type - Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 313: Africa 16-Year Perspective for Whole Genome Amplification (WGA) by Type - Percentage Breakdown of Value Sales for Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and Other Types for the Years 2014, 2025 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Whole Genome Amplification (WGA) by Application - Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 316: Africa 16-Year Perspective for Whole Genome Amplification (WGA) by Application - Percentage Breakdown of Value Sales for Other Applications, Drug Discovery & Development Application, Diagnostics Application, Research Application and Forensics Application for the Years 2014, 2025 & 2030
    • TABLE 317: Africa Recent Past, Current & Future Analysis for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Africa Historic Review for Whole Genome Amplification (WGA) by End-user - Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 319: Africa 16-Year Perspective for Whole Genome Amplification (WGA) by End-user - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-User, Hospitals & Clinics End-User, Research Institutes End-User and Other End-Users for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제